A 58-year-old man with type 2 diabetes is started on empagli…
A 58-year-old man with type 2 diabetes is started on empagliflozin. During follow-up, the nurse practitioner should instruct the patient to seek immediate medical attention if he develops which symptom because of an FDA safety warning associated with SGLT2 inhibitors?
Read Details